We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Formycon AG: Licensing Out of the First Biosimilar Development Project

News   Mar 13, 2014

 
Formycon AG: Licensing Out of the First Biosimilar Development Project
 
 
 

RELATED ARTICLES

Maybe "Leaky Gut" Should Be Considered in HIV Treatment

News

HIV-positive people treated with antiretroviral therapy who had high levels of autoantibodies also had increased levels of Staphylococcus aureus products in their blood, raising new possibilities of a "leaky gut" mechanism in HIV pathology.

READ MORE

“BridgIT” Identifies Candidate Genes and Catalyzing Proteins for Orphan and Novel Enzyme Reactions

News

Chemical engineers at EPFL have developed an online tool that can accurately assign genes and proteins to unknown “orphan” reactions, which are a major headache for biotechnology, drug development, and even medicine.

READ MORE

Protein "Spat Out" by Cancer Cells Promotes Tumor Growth

News

Prostate cancer cells change the behavior of other cells around them, including normal cells, by "spitting out" a protein from their nucleus.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE